Search

Extensive pilot plant experimental studies for a period of one year were carried out to study the impact of climatic conditions on the operational performance of an innovative Fresnel solar collecting system. The solar measurements revealed that the total yearly Direct Normal Irradiance (DNI) on the tested site amounts to 1132 kWh/m2. The thermal collector efficiency, which depends on climatic conditions such as solar insolation, ambient temperature, receiver temperature as well as heat losses, ranges from 60% to 80%. The cost effectiveness when the tested Fresnel solar collection system with solar multiple of 1.0 (limited to day time operation) is combined with a commercial thermal desalination plant is compared with one completely run by fossil fuel. The breakeven fuel cost whereby the levelized cost of water of the two cases will be equal is yielded at a fuel cost of $92/bbl. When the tested Fresnel solar collection system is run at a location with a relatively high annual DNI level (1937 kWh/m2), the fuel breakeven cost falls to $52/bbl. This study also revealed that combining a Fresnel solar collection system with an MED thermal desalination plant under specific climatic conditions is considered more cost effective when operated without thermal energy storage.

To elucidate factors associated with the very low risk of gastric neoplasia in Yogyakarta, Indonesia, approximately 1/50 of the level in Japan, we recruited 52 male and 39 female participants from the general populace in the city of Yogyakarta in October 2003. Helicobacter pylori IgG antibodies were found in only 5% (0-13) (95% confidence interval) and 4% (0-9) for Javanese males and females, respectively, and were statistically lower than the 62% (58-65) and 57% (53-60), respectively, in Japanese. Furthermore, positive findings of pepsinogen test were only 0 and 2% (0-6) for males and females, in Yogyakarta, and were again significantly lower than the 23% (22-25) and 22% (20-23), in Japan. The very low incidence of stomach cancer in Yogyakarta may be due to a low prevalence of H. pylori infection and chronic atrophic gastritis.

Although globalization urges corporations worldwide to pursue economic efficiency, culturally induced differences in corporate behavior persist in a globalized business world. This paper explores the behavior of Japanese corporations in this context. Interviews were conducted to investigate the internal decision-making process in major Japanese firms. Their outcome provides the basis for the following hypothesis: A unique characteristic of Japanese companies, which can be different from that of Western firms, is that they have similar managerial behavior with other Japanese companies in the same industry. The collectivity culture exists behind it. This hypothesis is attested by case analyses of historical events of two Japanese industries in the global market in the past half century. Japanese firms in the automotive and electronic industries exhibited similar behavior in their entries to foreign markets either in marketing or production.

Vesicles and bullae formation is rare in dermatomyositis. We describe a 60-year-old woman who presented with vesiculobullous dermatomyositis with panniculitis and no muscle disease.

A method for the determination of delta-aminolevulinic acid in plasma of lead-exposed workers by high-performance liquid chromatography with fluorescence detection of a fluorescent delta-aminolevulinic acid derivative (2-methylidineamino-3,5-diacetyl-4,6-dimethylpropionic acid) was established. The detection limit of delta-aminolevulinic acid in plasma was 0.01 microgram/ml at a signal-to-noise ratio of 5:1. A linear correlation was obtained between the amounts of delta-aminolevulinic acid injected from 0.01 to 0.5 microgram/ml (r = 0.999). The recovery of 0.05 and 0.1 microgram/ml of delta-aminolevulinic acid added to plasma with various concentrations of delta-aminolevulinic acid in plasma ranged from 80.0 to 100.8%. This method, combined with the use of an automatic sampler, should facilitate the routine measurement of delta-aminolevulinic acid in plasma.